Navigation Links
CPF Launches National PSA to Educate Public on Pulmonary Fibrosis
Date:3/20/2009

'Target' Video Dramatizes Message That Pulmonary Fibrosis Can Strike Anyone, Anywhere; Urges Americans to Work With CPF to Find a Cure

SAN JOSE, Calif., March 20 /PRNewswire-USNewswire/ -- Pulmonary Fibrosis (PF) claims a life every 13 minutes in the U.S., the same number of lives each year as to breast cancer; yet most Americans have never heard of the disease until it strikes them, or someone they love. The Coalition for Pulmonary Fibrosis (CPF) today launched a new public service announcement (PSA) to increase awareness of PF, which affects more than 128,000 Americans. Since 2001, prevalence has increased an alarming 156 percent, yet awareness and understanding of PF remains low in the general public and medical community. The goal of the PSA is to draw increased national attention to PF by educating the public on this rapidly progressing and ultimately fatal disease, and to urge people to support the CPF in its efforts to help patients and fund research efforts to find a cure.

The CPF's "Target 2009" PSA, is available online at: http://www.youtube.com/watch?v=O3qj0_paNF0&fmt=18

The CPF is distributing the PSA nationally through YouTube and Facebook, and broadcast-quality copies are also available for television outlets by contacting the CPF's Teresa Barnes at 888-222-8541, ext. 702..

The PSA, entitled 'Target', portrays a need for increased public awareness of PF by noting the rapidly increasing prevalence of the disease and the need to accelerate efforts to help patients, and understand and treat PF. The aggressive tone of the PSA highlights the ever-increasing need to work with the CPF to help the community of patients and researchers it serves,

"Our goal was to create a dramatic visual metaphor that clearly demonstrates the random and deadly nature of PF. The customized visual effect of an animated high tech moving target in an urban environment delivers a sobering message that 128,000 are now dying from PF with another 48,000 who will be 'targeted' this year by the deadly disease," said David C. Bojorquez, Director - Filmmaker with David Productions, the company that created the PSA for the CPF.

The video conveys the stealth nature of the fatal lung disease that targets its victims randomly. There is no known cause and there are no treatments, making PF a mystery to scientists, and a shocking and devastating diagnosis to patients and their families. It is the CPF's intention to create an open dialogue about the disease with the strong video message in hopes that it will lead to public support of the CPF's continuing efforts in patient services and research efforts to find a cure.

"We are so excited about this opportunity to share this well-produced video with the public. Our patients have long waited for a national voice in the media, and we are filling that void with this production," said Mishka Michon, chief executive officer for the CPF. "Our goal is for this video to spread virally throughout the Internet and for it to also be widely broadcast on television and cable stations nationwide. It is critically important that attention be paid before hundreds of thousands more lives are claimed by PF in the coming years."

Members and friends of the CPF can impact the success of this effort. If you are a patient, family member, or someone who was been affected by PF, we urge you to share the PSA with your network of friends, family, and colleagues. Just email this link: http://www.youtube.com/watch?v=O3qj0_paNF0&fmt=18

The message in the PSA is urgent with so many patients dying and the CPF is giving voice to the hundreds of thousands of patients who are waiting for treatment and a cure.

About Pulmonary Fibrosis (PF)

Pulmonary Fibrosis (PF) is a lung disorder characterized by a progressive scarring - known as fibrosis -- and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 128,000 Americans suffer from PF, and there is currently no known cause or cure. An estimated 48,000 new cases are diagnosed each year. PF is difficult to diagnose and an estimated two-thirds of patients die within five years of diagnosis. Sometimes PF can be linked to a particular cause, such as certain environmental exposures, chemotherapy or radiation therapy, residual infection, or autoimmune diseases such as scleroderma or rheumatoid arthritis. However, in many instances, no known cause can be established. When this is the case, it is called idiopathic pulmonary fibrosis (IPF).

About the CPF

The CPF is a 501(c)(3) nonprofit organization, founded in 2001 to accelerate research efforts leading to a cure for pulmonary fibrosis (PF), while educating, supporting, and advocating for the community of patients, families, and medical professionals fighting this disease. The CPF funds promising research into new approaches to treat and cure PF; provides patients and families with comprehensive education materials, resources, and hope; serves as a voice for national advocacy of PF issues; and works to improve awareness of PF in the medical community as well as the general public. The CPF's nonprofit partners include many of the most respected medical centers and healthcare organizations in the U.S. With more than 19,000 members nationwide, the CPF is the largest nonprofit organization in the U.S. dedicated to advocating for those with PF. For more information please visit www.coalitionforpf.org or call (888) 222-8541.


'/>"/>
SOURCE Coalition for Pulmonary Fibrosis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MEDRAD Multi Vendor Service Launches TotalRepair(SM) on Select Ultrasound Probes
2. Photo: ZonePerfect(R) Nutrition Bars Launches Nationwide Tour With VH1 Save The Music Foundation to Nourish Arts, Americas Schools
3. Askesis Development Group, Inc. Launches New Behavioral Health Software for Electronic Medical Records (EMR) and Practice Management
4. Nuvilex, Inc. Launches Spring Break Initiatives Designed to Raise Visibility Among Key Demographic Group
5. EAU launches new clinical guidelines for 2009 -- kidney cancer
6. MIT scientist launches special nanoscience symposia at ACS National Meeting
7. ESA launches first Earth Explorer mission GOCE
8. HRSA Launches Online Resource to Help Prevent Poisonings
9. HealthyPlace.com, the Largest Consumer Mental Health Site, Launches Mediminder, a Free Medication Reminder Tool for the More Than 30 Million People Who Suffer From Depression, Anxiety, Bipolar Disorder and Other Mental Health Conditions
10. Cardinal Health Launches New Products for the Operating Room
11. GeoFitness Launches Get Moving America Campaign to Improve Youth Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... CITY, Utah (PRWEB) , ... April 21, 2017 ... ... of wilderness therapy treatment for adolescents and young adults, has kicked off its ... 20th-Sunday, April 23rd. This year’s theme is “Attachment Informed Therapy for Mental ...
(Date:4/21/2017)... , ... April 21, 2017 , ... The Patient Advocacy ... Health System, with the 2017 Ruth Ravich Patient Advocacy Award in recognition ... advocates. DeVaro was honored with the award at The Beryl Institute’s annual Patient ...
(Date:4/21/2017)... ... ... Alive for Wellness is a group of clinical professionals and ... Alive team uses advanced behavioral sciences treatment modalities to accomplish their goals. ... struggle is based on 10 modalities of treatment that include: , ...
(Date:4/21/2017)... Ramon, CA (PRWEB) , ... April 21, 2017 , ... ... might not understand the estate planning process, or where to even begin. “Now more ... unresolved if you are to properly protect yourself and your family,” said attorney Lisa ...
(Date:4/21/2017)... ... , ... During April 21-23, Super-Sod will join the vendor market of the ... everyone — from the avid gardener to the landscape admirer — during the three-day ... in a grand venue, and we are certainly looking forward to participating in this ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical Center ... in Nashville , Tennesse have been ... Sphincter Stimulation for GERD (LESS GERD) trial. The EndoStim ... long-term reflux control by restoring normal function to the ... million people in the United States ...
(Date:4/19/2017)... 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and other unmet ... previously announced underwritten public offering of 23,625,084 shares ... price of $2.00 per share, before deducting underwriting ... by Sorrento.  The net proceeds to Sorrento from ...
(Date:4/19/2017)...  New research provides evidence that an old drug may ... study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... disease, the oral drug levodopa has long been considered the ... the disease progresses, the effects of the medication can partially ...
Breaking Medicine Technology: